Article
A treatment approach that uses a donor's immune cells appears to provide anti-cancer activity in some patients with recurrent or refractory renal cell carcinoma, according to research published in the Journal of Clinical Oncology (2003; 21: 3785-91).
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.